Product overview
Type
Influenza, Pandemic (H1N1)
Commercial Name
Panvax
Manufacturer
Seqirus Limited
URL
Responsible NRA
Therapeutic Goods Administration
Country
Australia
URL
Prequalification
Prequalification Status
Current: No Routine Production
Product description
Pharmaceutical Form
Liquid: ready to use
Presentation
Vial
Number of Doses
10
Diluent
Not Applicable
Route of Administration
Intramuscular or deep subcutaneous
Shelf Life
12 months
Storage Temperature
2-8°C
Vaccine Vial Monitor
none
Secondary Packaging
Carton of 10 vials [Dimensions: 5.0 x 11.2 x 5.5]
Tertiary Packaging
Box of 78 cartons of 10 vials (780 vials/7800 doses) [Dimensions: 45 x 29.5 x 23.5 cm]
Multidose Vial Policy
WHO recommends that opened vials of this vaccine may be kept for use in subsequent immunization sessions (up to a maximum of 28 days) provided the conditions outlined in the WHO Policy Statement: The use of opened multi-dose vials of vaccine in subsequent immunization sessions are met.
Vaccine Preservative
thiomersal
Vaccine Preservative Concentration
0.1 mg/ml
Cold Chain Volume
3.08 cm3/dose (in secondary packaging)
Attachments
